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Background: Shoulder pain and dysfunction are common after oncologic neck dissection for head and neck
cancer (HNC), due to traction, compression, and devascularization injuries to the spinal accessory nerve (SAN).
Shoulder pain and dysfunction can hinder postoperative rehabilitation and hygiene, activities of daily living (ADLs),
and return to work after treatment for HNC. Due to the rising incidence of human papillomavirus (HPV)-associated
oropharyngeal cancer, patients are often diagnosed in the third or fourth decade of life, leaving many potential
working years lost if shoulder dysfunction occurs. Brief electrical stimulation (BES) is a novel technique that has
been shown to enhance and accelerate neuronal regeneration after injury through a brain-derived neurotrophic
growth factor (BDNF)-driven molecular pathway in multiple peripheral nerves in both humans and animals.
Methods/Design: This is a randomized controlled trial testing the effect of intraoperative BES on postoperative
shoulder pain and dysfunction. All adult participants with a new diagnosis of HNC undergoing surgery with neck
dissection, including Level IIb and postoperative radiotherapy, will be enrolled. Participants will undergo intraoperative
BES after completion of neck dissection for 60 min continuously at 20 Hz, 3 to 5 V, in 100-msec pulses. Postoperatively,
participants will be evaluated using the Constant-Murley Shoulder Score, a scale that assesses shoulder pain, ADLs,
strength, and range of motion. Secondary outcomes measured will include nerve conduction studies (NCS) and
electromyographic (EMG) studies, as well as scores on the Oxford Shoulder Score (OSS), the Neck Dissection
Impairment Index (NDII), and the University of Washington Quality of Life (UW-QOL) score. Primary and secondary
outcomes will be assessed at 6 weeks, 3 months, 6 months, and 12 months.
Discussion: The objective of this study is to evaluate the effect of BES on postoperative clinical and objective
shoulder functional outcomes and pain after oncologic neck dissection. BES has been shown to be successful in
accelerating peripheral nerve regeneration in both animal and human participants in multiple different peripheral
nerves. If successful, this technique may provide an adjunctive prevention option for shoulder pain and dysfunction
in HNC patients.
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Head and neck cancer (HNC) is now the fifth most com-
mon cancer in the world due to the rising incidence of
oropharyngeal cancer (OPC) from increased transmission
of the human papillomavirus (HPV) [1]. HPV-associated
oropharyngeal cancer (HPV-OPC) most commonly occurs
in patients in the third or fourth decade of life [2]. Ad-
vanced HNC, including OPC, is often treated with resec-
tion, which includes a neck dissection, or extirpation of
lymph nodes known to be, or possibly infiltrated, by locor-
egional cancer spread [3].
During the neck dissection, Levels II and V are often
dissected. The spinal accessory nerve (SAN) courses
through these levels, and thus, is also subject to dissec-
tion. Often, retraction and manipulation of the SAN,
which innervates the trapezius and sternocleidomastoid
muscles, is necessary to access Levels II and V [4]. Fur-
thermore, the superior 5 cm of the SAN is often devascu-
larized in a Level IIb dissection in order to skeletonize all
lymphatic tissues off the nerve [5].
Devascularization and retraction of the SAN results in
axonal injury, which can give rise to shoulder pain and
dysfunction postoperatively, even in nerve-sparing pro-
cedures [6]. Particularly, thorough dissection of Level
IIb and Level V can contribute to these symptoms [7].
Shoulder pain and dysfunction from SAN injury has
pronounced negative effects on quality of life, which are
well-documented [8]. Furthermore, as the majority of
HNC patients are male and still of working age [9], the
ramifications of shoulder pain and dysfunction can also
have a socioeconomic impact.
In the last two decades, it has been demonstrated, in
both humans and animal models, that application of
intraoperative brief electrical stimulation (BES) to trans-
ected motor and sensory nerves promotes axonal out-
growth and, thereby, enhances nerve regeneration [10].
In these studies of motoneurons, 60 min of BES at
20 Hz was shown to be as effective as continuous stimu-
lation for 2 weeks, suggesting that BES should be a
clinically viable technique [10].
A randomized control trial in human participants
with carpal tunnel syndrome (CTS) was initiated at the
University of Alberta. BES was applied for 1 h following
carpal tunnel release and compared to a sham control
group using motor unit number estimation (MUNE) and
sensory and motor nerve conduction studies (NCS). Six
months after BES was applied, MUNE was found to be
significantly higher in the BES group, and terminal motor
latency and sensory nerve conduction values improved
significantly faster than in controls [11].
Given the previously demonstrated success of this
technique in other motor nerves, we elected to examine
its application to the SAN in a patient population who
are in the prime of their working years.Objective
The aim of this study is to assess the efficacy of BES on
postoperative clinical and objective shoulder functional
outcomes and pain in HNC patients undergoing onco-
logic neck dissection.
Hypothesis
We hypothesize that the use of intraoperative BES will
enhance recovery of the SAN and decrease shoulder
pain and dysfunction after oncologic neck dissection.
Methods/Design
The study will be conducted as a double-blinded, ran-
domized controlled trial. Participants will be identified
for eligibility from the Northern Alberta Head and Neck
Tumor Board (NAHNTB), and will be recruited from
the University of Alberta Otolaryngology Clinic after diag-
nosis of HNC has been confirmed. All surgeries will take
place at the University of Alberta Hospital. Informed writ-
ten consent will be obtained from each participant prior
to enrollment in the study and will be sought at the time
of surgical booking. Two parallel treatment groups will be
examined with a 1:1 allocation: 1) Brief intraoperative
electrical stimulation continuously at 20 Hz, 3 to 5 V, at
0.1-msec pulses for 60 min, or 2) No stimulation.
Subjects
Participants will undergo a screening recruitment check-
list to determine eligibility for the study.
Eligibility criteria
Inclusion criteria
 Age >18 years
 New diagnosis of head and neck cancer
 Undergoing major resection and reconstruction
surgery with oncologic neck dissection including
Level IIb or V
Exclusion criteria
 Oncologic resection necessitating unilateral or
bilateral resection of the sternocleidomastoid, SAN,
or partial resection of trapezius muscle due to
tumor invasion
 Previous surgery or radiation therapy to the head
and/or neck
 Recurrent head and neck cancer
 Pre-existing shoulder pain, dysfunction or weakness,
including myopathy, neuropathy, or arthropathy at
the time of the pre-operative assessment
 Presence of existing implanted electrical device
(for example, pacemaker, deep brain stimulator,
vagal nerve stimulator)
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adversely affect shoulder dysfunction
 Unable to read, write, and speak English
 Lacking capacity to give consent
 Unwilling to present for follow-up appointments or
perform follow-up objective shoulder assessment
Randomization
Participants will be randomized to receive: 1) BES, or
2) No Stimulation, with a 1:1 allocation scheme. The
randomization sequence was computer-generated, assign-
ments placed on cards and concealed in sequentially num-
bered sealed opaque envelopes. After general anesthesia
has been administered, a card will be removed from the
respective opaque envelope by the circulating operating
room nurse, who is not involved in the study. This card
will dictate the treatment as stated above. If oncologic
neck dissection including Level IIb will be performed
bilaterally, the neck with the most extensive nodal burden
in Level IIb will be selected for randomization. This will
be decided based on preoperative imaging and confirmed
with intraoperative findings prior to randomization.
Blinding
Randomization and treatment will occur in the operat-
ing room on the day of surgery. All participants will be
blinded to the study group into which they have been
placed. The physiotherapist and neurophysiologist who
will be performing the study assessments including
administering the patient-reported questionnaires will
also be blinded to the treatment received by the partici-
pant, and will not be present in the operating room at
the time of randomization or treatment. Therefore, the
only study investigators aware of study group allocation
for each participant will be the surgeons, who are not
involved in measuring outcomes.
Primary outcome measure
The primary outcome will be a clinical assessment using
the Constant-Murley Shoulder Score, a valid and reliable
100-point scale composed of individual parameters asses-
sing shoulder function and pain [12, 13]. This assessment
tool includes four subscales that assess pain, activities of
daily living (ADLs), strength, and range of motion. A
higher score indicates higher functioning. A physiother-
apist (MM) will assess shoulder function using this scale.
Assessments will occur pre-operatively and at 6 weeks, 3,
6, and 12 months postoperatively.
Secondary outcome measures
Secondary outcomes will include both self-report out-
comes as well as objective measures of SAN function.
Self-report measures include the Oxford Shoulder Score
(OSS), the Neck Dissection Impairment Index (NDII),and the University of Washington Quality of Life (UW-
QOL) questionnaire. The OSS is a 12-item, self-report,
validated questionnaire regarding shoulder-specific daily
activity in the previous 4 weeks [14–16]. The NDII is a
validated ten-item self-report questionnaire using a five-
point Likert scale for assessment of shoulder and neck
discomfort as it relates to ADLs [17]. Quality of life will
be assessed on the UW-QOL, a validated self-report ques-
tionnaire detailing quality of life in 12 domains specific to
head and neck cancer symptoms [18–20]. Objective
measures of nerve function will include NCS and elec-
tromyographic (EMG) studies and will be completed
by a neurophysiologist (KMC). All secondary outcomes
will be assessed pre-operatively and at 6 weeks, 3, 6,
and 12 months postoperatively.
Interventions
Group 1: BES group
Participants randomized to the BES group will undergo
intraoperative BES immediately post-neck dissection con-
tinuously at 20 Hz, at 3 to 5 V, in 100-msec pulses for
60 min. Electrical stimulation will be performed by encirc-
ling the nerve with fine wire electrodes placed at (anode)
and just proximal to (cathode) the region of the nerve
under maximal traction, and will be executed using the
Grass SD9 Stimulator (Quincy, MA, USA). Voltage will be
titrated in an ascending fashion from 1 to a maximum of
5 V in order to obtain a palpated contraction of the
trapezius muscle.
Group 2: control (no stimulation) group
Participants randomized to the control group will
receive no stimulation, as per current standard of care.
Sample size justification
A sample size of 30 participants in each group will be
sufficient to detect an 11 % difference in the Constant-
Murley Shoulder Score from the 6-week postoperative
time point to the 6-month follow-up in favor of the BES
group (power of 80 %; significance: 5 %). In the postop-
erative period, participants can be expected to exhibit a
significant decrease in the Constant-Murley Shoulder
Score from the pre-operative assessment [8]. For each
participant the percentage improvement will be relative
to his/her pre-operative score. We are assuming an
improvement of 36 % in the BES group, and a 25 %
improvement in the control group at the 6-month
follow-up. The sample size will be increased to 36 par-
ticipants per group to account for an attrition rate of
20 % and to allow adequate power for analysis secondary
outcomes. The 6-month follow-up was chosen as the
primary time end point based on findings from previous
research at the University of Alberta demonstrating
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following carpal tunnel release at this time point.
Statistical analysis
Baseline medical and demographic characteristics, surgi-
cal type (MRND versus SND) and adverse events of the
two groups will be compared using an independent t-test
for continuous data and Pearson’s Chi-square tests for
categorical data. The primary analysis will compare the 2
groups with regard to percent change in the Constant-
Murley Shoulder Score from the 6-week postoperative
time point to the 6-month follow-up using an independ-
ent t-test. Secondary outcomes and time points will be
analyzed by repeated measures modeling and independ-
ent t-tests on change scores.
Safety and potential risks
The risk associated with this procedure is a theoretical
risk of increased pain in the immediate postoperative
period due to the electrical stimulation. During this
time, the participant will be administered pain medica-
tion as is standard protocol for all patients undergoing
major resection and reconstruction surgery, given the
extent of the resection and free flap elevation.
The safety parameters that will be monitored in this
study are vital signs and arrhythmias, and any adverse
event (AE) or serious adverse event (SAE). Specifically,
an AE may be defined as any adverse reactions that can
be specifically attributed to the use of electrical stimula-
tion (for example, charring, visible nerve injury). A SAE
may be defined as any AE that can be specifically attrib-
uted to the use of electrical stimulation and will include,
but is not limited to, cardiac arrhythmias causing instabil-
ity, or cardiac arrest. No AE or SAE has occurred in any
previous BES trials involving humans or animals.
Trial management
The Trial Steering Committee (TSC) in accordance with
Good Clinical Practice Guidelines will manage the trial
(Chair: DO). All lead investigators and authors of this
paper will be TSC members. The Trial Management
Committee (BB, DO, MC, MM, RB) will be responsible
for the day-to-day running of the trial. A Data Safety
Monitoring Board (DSMB) has been assembled and
approved to monitor AEs and SAEs. The DSMB will be
responsible for safeguarding the interests of the trial par-
ticipants, potential participants, and investigators.
Research team responsibilities
KMC is a neurophysiologist and Professor in the Division
of Physical Medicine and Rehabilitation. He has extensive
experience in pioneering and refining the electrical stimu-
lation protocol, and will be responsible for conducting
EMG studies and NCS. BB is an otolaryngology-head andneck surgery resident and will be responsible for perform-
ing the electrical stimulation process intraoperatively.
MM is a physiotherapist with extensive experience in
physical rehabilitation after oncologic neck dissection, and
will be performing all clinical shoulder assessments
utilizing the Constant-Murley Shoulder Score. RB is a
graduate student in rehabilitation medicine who will assist
in the data collection of objective and patient-reported
outcomes. DO is a microvascular head and neck surgeon
and will be responsible for recruiting participants and
ensuring self-report questionnaires are completed by par-
ticipants. HS is a microvascular surgeon and has been
instrumental in refining the intraoperative BES tech-
nique. JH and JO assisted with study design and critique
and will be involved in results analysis and manuscript
preparation.Ethics
This study will be conducted in accordance with Good
Practice Guidelines and has received ethical and oper-
ational approval (Pro00046671) by the Human Research
Ethics Board (HREB) and Northern Alberta Clinical
Trials and Research Center (NACTRC) at the University
of Alberta.Discussion
The primary objective of this study is to evaluate the ef-
fect of intraoperative BES on SAN recovery following
traction, compression, and devascularization injury dur-
ing oncologic neck dissection. The SAN is the principal
motor innervation to the trapezius muscle, a key stabiliz-
ing muscle of the scapula [21]. The trapezius allows use
of the arms for lifting, carrying and overhead work. Par-
alysis or weakness of the trapezius alters the alignment
of the neck and shoulder region, and disrupts the nor-
mal movement of the shoulder complex [4, 22]. Chronic
neck and shoulder dysfunction are common after neck
dissection procedures, negatively impacting both quality
of life and return to work [23, 24]. Thus, strategies are
needed that help reduce the impact of neck dissection
procedures on shoulder function while still ensuring
optimal oncologic outcomes.
A significant body of evidence has been put forth
regarding the success of BES in promoting regeneration
following peripheral nerve injuries. To our knowledge,
intraoperative BES has not previously been applied to
the SAN for the purposes of alleviating pain or prevent-
ing shoulder dysfunction, specifically after oncologic neck
dissection. However, the use of surface BES in treatment
of neuropathic pain, particularly in peripheral nerve disor-
ders, has been well-established [25]. More specifically, a
study by Wilson et al. [12] demonstrated a significantly
greater reduction in pain with application of percutaneous
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dle deltoid, and posterior deltoid muscles.
The application of BES to a peripheral nerve following
injury was initially performed by Nix and Hopf [26], in
the soleus nerve of a rabbit after a crush injury. They
subsequently reported accelerated recovery of twitch
force, tetanic tension, and muscle action potential in the
soleus muscle. Thereafter, application of BES to the sciatic
nerve proximal to a crush injury demonstrated signifi-
cantly improved recovery of the toe-spread reflex [27].
Despite evidence of improved and accelerated motor func-
tion in previously-injured peripheral nerves, at that time,
the mechanism of BES was not yet elucidated.
Further studies demonstrated that, following applica-
tion of BES to the rat femoral nerve after transection in-
jury and primary repair, significantly increased numbers
of motoneurons regenerated into the nerve branches of
the rat femoral nerve when compared to a non-stimulated
sham control group. This acceleration of function recov-
ery was found to be due to accelerated sprouting of axons
across the nerve repair site and not due to an accelerated
rate of regeneration [28]. Subsequent studies have sug-
gested that brain-derived neurotrophic factor (BDNF), a
key molecule in activating cyclic adenomonophosphate
(cAMP) and protein kinase A (PKA), which lead to down-
stream protein transcription necessary for neurite out-
growth, may be mediating the effect of BES in accelerating
motoneuron regeneration [29]. Thus, a rationale for the
use of BES clinically is supported by the findings of this
research.
Study limitations
A limitation of our study is the relatively small sample
size given the potential heterogeneity in surgical proce-
dures among patients. The sample size may ultimately
limit our ability to examine subgroup differences such as
the effect on those undergoing modified radical neck
dissection compared to selective neck dissection. Should
BES prove safe and show preliminary efficacy, explora-
tory analyses will be carried out on sub-groups undergo-
ing SND and MRND to determine point estimates and
measures of variability for the purposes of a larger Phase
III study.
The study was powered to detect a minimal clinically
significant difference (MCID) in the Constant-Murley
Shoulder Score of 10.4 % (standard deviation: 15) based
on previous research following post-surgical rotator cuff
injuries [30, 31]. The MCID for the Constant-Murley
Shoulder Score following neck dissection procedures is
currently not known. A previous study reported average
scores in the range of 70 % following neck dissection
surgery, with larger deficits seen in those who had under-
gone more extensive procedures [8]; thus, we hypothesize
that an improvement of 10 % would likely be clinicallyrelevant following oncologic neck dissection for head and
neck cancer.
A potential confounder in the study is related to pain
sustained from operative incisions. However, this is
unlikely to confound the outcomes, as we anticipate
similar levels of pain in both groups in the early stages.
Additionally, the first follow-up measurement (6 weeks
postoperatively) falls outside the acute pain stage.
Relevance
The potential impact of this study is multi-dimensional.
First, if successful, this study will confirm findings from
previous human trials at the University of Alberta that
have demonstrated accelerated axonal regeneration his-
tologically, as well as, clinically improved functioning of
both motor and sensory nerves. In addition, evaluation
of this technique as a therapy for axonal devasculariza-
tion injuries will further define its role in diverse periph-
eral nerve injuries. Furthermore, and most importantly,
should this technique be successful, it will provide an
additional therapeutic option for the prevention of shoul-
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